Akonni Biosystems receives $3.

Akonni Biosystems receives $3.2M Phase II SBIR grant from NIH Akonni Biosystems, a molecular diagnostics company focused on providing fast and highly scalable solutions for infectious disease assessment, today announced receipt of a $3.2M Stage II SBIR grant from the National Institutes of Wellness cialis . The award will enable Akonni to combine PCR using its existing TruArray gel-drop microarray in one chamber, closed-amplicon program, and field test drive it for the recognition of influenzas A and B and their antigenic subtypes, including antiviral resistant types. This grant is based on the successful completion of an earlier Stage I SBIR, and offers as an objective the production of commercial products for scientific and research laboratories.D., CEO of Akonni Biosystems.